文献速递内脏/肾动脉与血管畸形

肠系膜动脉支架长期结局及支架内再狭窄超声速度标准分析

Long-Term Outcomes of Mesenteric Stenting and Analysis of In-Stent Restenosis Duplex Velocity Criteria.
PubMed 文献 · Ann Vasc Surg · 2020-05-16

单中心回顾性分析61例慢性肠系膜缺血患者(71条动脉)肠系膜支架置入的长期结局,并探索与支架内再狭窄相关的多普勒速度阈值。1、2、3年免于再干预率分别为83%、73%、60%,覆膜支架与裸金属支架通畅率无显著差异。腹腔干支架PSV 440 cm/s诊断临床显著ISR敏感度100%、特异度86%,肠系膜上动脉支架未找到类似阈值。

要点

  • 腹腔干支架PSV 440 cm/s对临床显著ISR敏感度100%、特异度86%。
  • 肠系膜上动脉支架PSV 341 cm/s诊断ISR敏感度仅80%、特异度52%。
  • 覆膜支架与裸金属支架通畅率无显著差异(OR 0.45;95%CI 0.15-1.33;P=0.1383)。

核心结论

  • 腹腔干支架PSV 440 cm/s提示临床显著ISR,敏感度和特异度优良,应结合临床表现识别可能受益于再次干预的患者。
  • 肠系膜上动脉支架未能确定类似阈值,需进一步协作研究。

研究设计与样本

  • 单中心回顾性综述,纳入2012-2018年因慢性肠系膜缺血行肠系膜支架置入的患者。
  • 共61例患者、71条动脉,平均年龄72岁(范围49-92),女性占55%。

主要发现

  • 1年、2年、3年免于再干预率分别为83%、73%、60%。
  • 1年、2年、3年免于闭塞或旁路移植率分别为100%、86%、86%。
  • 覆膜支架与裸金属支架通畅率无显著差异(OR 0.45;95%CI 0.15-1.33;P=0.1383)。
  • 中位生存期6.1年。

关键数值与推荐

  • 腹腔干支架:PSV 440 cm/s对应临床显著ISR,敏感度100%,特异度86%。
  • 肠系膜上动脉支架:PSV 341 cm/s对应临床显著ISR,敏感度80%,特异度52%。

临床怎么用

  • 腹腔干支架术后可参考PSV 440 cm/s阈值结合临床症状评估ISR,以识别需再次干预者。
  • 肠系膜上动脉支架术后不宜直接套用PSV 341 cm/s阈值,需结合临床综合判断。

局限性

  • 单中心回顾性设计,样本量有限(61例患者、71条动脉)。
  • 肠系膜上动脉支架的PSV阈值敏感度和特异度欠佳,未确定可靠标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endovascular therapy for chronic mesenteric ischemia (CMI) is the mainstay of treatment. Duplex velocity criteria within stented mesenteric vessels are not well established. We describe single-center outcomes of mesenteric stenting for CMI and analyze duplex velocities associated with in-stent restenosis (ISR). METHODS: We performed a single-center retrospective review of patients undergoing mesenteric stenting for CMI (2012-2018). Primary outcome was reintervention for recurrence of CMI symptoms. Secondary outcomes were occlusion or bypass grafting. Duplex velocities in those with recurrent symptoms, corresponding with clinically significant ISR, were identified. Receiver operating characteristic (ROC) curves were created to identify velocity thresholds for ISR. RESULTS: Mesenteric stents were placed in 61 patients (71 arteries). Mean age was 72 years (range, 49-92), and the majority were female (55%). Thirty-two (45%) celiac (CA) stents and 39 (55%) superior mesenteric artery (SMA) stents were placed. Ten patients had SMA and CA stents placed. Twenty-five stents were covered (35%). Freedom from reintervention at 1, 2, and 3 years was 83%, 73%, and 60%. Freedom from occlusion or bypass grafting at 1, 2, and 3 years was 100%, 86%, and 86%. No significant difference in patency was seen between covered and bare-metal stents (OR 0.45; 95% CI: 0.15-1.33; P = 0.1383). Median survival was 6.1 years. For CA stents, a peak systolic velocity (PSV) of 440 cm/s corresponded with clinically significant ISR with 100% sensitivity and 86% specificity. For SMA stents, a PSV of 341 cm/s corresponded with clinically significant ISR with only 80% sensitivity and 52% specificity. CONCLUSIONS: A PSV of 440 cm/s for CA stents was indicative of clinically significant ISR with excellent sensitivity and specificity. This should be used in conjunction with clinical findings to identify patients that may benefit from repeat intervention. A similar threshold could not be identified for SMA stents and warrants further collaborative investigation.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Barnes JA, Columbo JA, Ponukumati AS, et al. Long-Term Outcomes of Mesenteric Stenting and Analysis of In-Stent Restenosis Duplex Velocity Criteria. Ann Vasc Surg. 2020. PMID: 32428638. doi:10.1016/j.avsg.2020.04.064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。